After careful consideration, CME Group will be winding down most of its regulatory reporting services, on or by 30th November 2020.
This decision follows an evaluation of our Regulatory Reporting business portfolio following the acquisition of NEX Group in November 2018 which determined it no longer aligns with the strategic direction of CME Group.
For more information please click here.
“Being recognised by the industry itself is a testament to the firm’s service excellence which we are truly proud of.”
Jo Davies, Head of CME Regulatory Reporting
End-to-end solution for all your regulatory reporting.
Our specialist consultancy, proven technology and exceptional service addresses the needs of reporting parties across global regimes, including:
EMIR (European Market Infrastructure Regulation)
CME Regulatory Reporting helps OTC and ETD trading counterparties evaluate and prepare fully compliant EMIR reports
SFTR (Securities Financing Transactions Regulation)
CME Regulatory Reporting will deploy a solution that builds on the expertise gained in other reporting regimes to deliver a service that exceeds market standards
As an ARM (Approved Reporting Mechanism) we evaluate individual reporting situations and implement customised solutions compliant with all MiFID II/R reporting rules
MAS (Monetary Authority of Singapore)
CME Regulatory Reporting provide customised solutions that ensure clients meet their MAS reporting requirements
Latest News and Opinions
Follow us on Twitter
Latest Twetter Feeds
